AEterna Zentaris Inc. (AEZS-T) Stock Predictions - Stockchase
WATCH LIST
3
AEterna Zentaris Inc. (AEZS-T)

ON STOCKCHASE SINCE Sep 2004

biotechnology/pharmaceutical

AEterna Zentaris Inc.

AEZS-T

4 watching          
Join the Discussion

AEterna Zentaris Inc. (AEZS-T) SAVE Apr, 24, 2019, 5:28 pm

5.24 0.17 (3.14%)

About AEterna Zentaris Inc. (AEZS-T)

Æterna Zentaris Inc. is a Quebec, Canada-based biopharmaceutical drug development company focused in oncology and endocrine therapy, currently investigating treatments for various unmet medical needs. More at Wikipedia

What the experts are saying about AEZS-T



  • All
  • Filtered
Signal Opinion Expert
SELL
Rather bad couple of days. Was down substantially, outside of a range. Consolidated. It broke down and is more likely to go down. $1.50 on the downside.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Rather bad couple of days. Was down substantially, outside of a range. Consolidated. It broke down and is more likely to go down. $1.50 on the downside.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Jeff Parent B.

VP & Portf, Castlemoore Inc....

Price Price
$1.640
Owned Owned
Unknown

TOP PICK
His stock filter picked stocks on a momentum basis and where money was flowing into them. The low it hit recently is a meaningful low. Likes the sector and feels it has been oversold. Do not let it violate the March low.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
His stock filter picked stocks on a momentum basis and where money was flowing into them. The low it hit recently is a meaningful low. Likes the sector and feels it has been oversold. Do not let it violate the March low.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Bill Carrigan

Technical , Getting Technical In...

Price Price
$4.390
Owned Owned
No

BUY on WEAKNESS
AEterna Zentaris Inc.(AEZS-T) 

September 7, 2004

Would like to get in at the $6 level. Cash flow positive.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Would like to get in at the $6 level. Cash flow positive.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Werner Muehelem

Vice Presi, ING Funds...

Price Price
$7.420
Owned Owned
No

Showing 1 to 3 of 3 entries
Successfully Saved Company
Successfully Saved Company